• Conclusion
In conclusion, PHI treatment exhibited significant improvements in UC by
inhibiting the activation of the NLRP3 inflammasome via the
TLR4/MyD88/NF-κB pathway. These findings provide potential mechanisms
underlying the therapeutic effects of PHI on UC.